Pedersen T F, Budtz-Lilly J, Petersen C N, Hyldgaard J, Schmidt J-O, Kroijer R, Grønholdt M-L, Eldrup N
Department of Heart, Lung and Vascular Surgery Aarhus University Hospital Aarhus Denmark.
Department of Vascular Surgery Aalborg University Hospital Aalborg Denmark.
BJS Open. 2018 Mar 26;2(3):112-118. doi: 10.1002/bjs5.55. eCollection 2018 Jun.
Remote ischaemic preconditioning (RIPC) has been suggested as a means of protecting vital organs from reperfusion injury during major vascular surgery. This study was designed to determine whether RIPC could reduce the incidence of perioperative myocardial infarction (MI) during open surgery for ruptured abdominal aortic aneurysm (AAA). Secondary aims were to see if RIPC could reduce 30-day mortality, multiple organ failure, acute intestinal ischaemia, acute kidney injury and ischaemic stroke.
This randomized, non-blinded clinical trial was undertaken at three vascular surgery centres in Denmark. Patients who had open surgery for ruptured AAA were randomized to intervention with RIPC or control in a 1 : 1 ratio. Postoperative complications and deaths were registered, and ECG and blood samples were obtained daily during the hospital stay.
Of 200 patients randomized, 142 (72 RIPC, 70 controls) were included. There was no difference in rates of perioperative MI between the RIPC and control groups (36 versus 43 per cent respectively), or in rates of organ failure. However, in the per-protocol analysis 30-day mortality was significantly reduced in the RIPC group (odds ratio 0·46, 95 per cent c.i. 0·22 to 0·99; P = 0·048).
RIPC did not reduce the incidence of perioperative MI in patients undergoing open surgery for ruptured AAA. Registration number: NCT00883363 ( http://www.clinicaltrials.gov).
远程缺血预处理(RIPC)已被提议作为在大血管手术期间保护重要器官免受再灌注损伤的一种手段。本研究旨在确定RIPC是否能降低腹主动脉瘤破裂(AAA)开放手术期间围手术期心肌梗死(MI)的发生率。次要目的是观察RIPC是否能降低30天死亡率、多器官功能衰竭、急性肠缺血、急性肾损伤和缺血性中风。
这项随机、非盲临床试验在丹麦的三个血管外科中心进行。接受AAA破裂开放手术的患者按1:1比例随机分为接受RIPC干预组或对照组。记录术后并发症和死亡情况,并在住院期间每天采集心电图和血样。
在随机分组的200例患者中,142例(72例RIPC组,70例对照组)被纳入。RIPC组和对照组之间围手术期MI发生率无差异(分别为36%和43%),器官衰竭发生率也无差异。然而,在符合方案分析中,RIPC组30天死亡率显著降低(优势比0.46,95%置信区间0.22至0.99;P = 0.048)。
RIPC并未降低接受AAA破裂开放手术患者围手术期MI的发生率。注册号:NCT00883363(http://www.clinicaltrials.gov)。